DOI:
10.1055/s-00034612
Yearbook of Medical Informatics
LinksClose Window
References
Lee JM, Hays JL, Annunziata CM, Noonan AM, Minasian L, Zujewski JA. , et al.
Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analyses.
J Natl Cancer Inst 2014;
106 (06) dju089
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.